Opsens (OPS) Stock Price, News & Analysis

Company Overview

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for cardiovascular interventions. The company operates in two segments, Medical and Industrial. The company provides advanced optical-based pressure guidewire (OptoWire), a guidewire used in the transcatheter aortic valve replacement procedure; and a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated in other medical devices. It also develops, manufactures, and markets medical products; and offers OPP-GD fiber optic differential pressure sensors and the OEC fiber optic extensometer sensors. The company serves life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and various other markets. The company sells its products through a network of distributors and direct sales force in the United States, Japan, Canada, and internationally. Opsens Inc. was formerly known as Capital DCB inc. and changed its name to OpSens Inc. in October 2006. The company was founded in 2003 and is headquartered in Québec, Canada. As of December 12, 2023, Opsens Inc. operates as a subsidiary of Haemonetics Corporation.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 49,783 shs
• Average Volume: 112,402 shs
• Market Capitalization: C$335.47 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 6/29/2017
• Today: 9/04/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: TSE:OPS
• CIK: N/A
• Web: opsens.com
• Phone: 418-781-0333
• Fax: N/A
• Employees: 293
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.11)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$12.40 million
• Net Margins: -25.65%
• Pretax Margin: N/A
• Return on Equity: -36.43%
• Return on Assets: -15.76%

Debt

• Debt-to-Equity Ratio: 27.22
• Current Ratio: 4.42
• Quick Ratio: 3.56

Sales & Book Value

• Annual Sales: C$48.35 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 8.68
• Book Value: C$0.29 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 115,680,000
• Free Float: N/A
• Market Cap: C$335.47 million
• Optionable: Not Optionable
• Beta: 0.32